SCHEMBL19010474

SCHEMBL19010474

Cc1c(-c2ccccc2)ccc2c3ccccc3n(-c3ccccc3)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.52
KDM4E B2RXH2 2/20 0.52
ATM Q13315 1/20 0.52
KMT2A Q03164 2/20 0.40
IL1R1 P14778 1/20 0.40
HTT P42858 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
PLA2G2A P14555 1/20 0.38
MAPK8 P45983 1/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
ALKBH5 Q6P6C2 1/20 0.37
FTO Q9C0B1 1/20 0.37
PGR P06401 2/20 0.36
HSD17B10 Q99714 1/20 0.36
HSP90AA1 P07900 1/20 0.36
IDO1 P14902 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21742787 0.85 L3MBTL1 (0.49) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL21498177 0.85 KDM4E (0.49) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL24356680 0.84 L3MBTL1 (0.55) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL21407075 0.84 L3MBTL1 (0.55) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL26267270 0.82 KDM4E (0.57) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL28308047 0.81 L3MBTL1 (0.52) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL23204139 0.81 L3MBTL1 (0.55) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL23813504 0.81 KDM4E (0.55) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL16491724 0.80 L3MBTL1 (0.59) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL10205983 0.80 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AIL1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814403-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-14 US disclosed
US-11814403-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-11-14 US disclosed
US-20210284672-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-09-16 US disclosed
US-20200216481-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2020-07-09 US disclosed
WO-2017102064-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284672-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDCD1, TEC, PDCD4 L3MBTL1 1605/4885KDM4E 2942/4885ATM 798/4885
US-11814403-B2 Organic electroluminescent materials and devices PDCD1, TEC, PDCD4 L3MBTL1 1658/4885KDM4E 2995/4885ATM 726/4885
US-20200216481-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDCD1, TEC, PDCD4 L3MBTL1 1658/4885KDM4E 2995/4885ATM 726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.